Ka Hoʻolālā ʻana i nā Kūlana Peptide no Luminex Multiplex Immunoassays: He Kuʻuna Mākaukau Lab

Pane wikiwiki

A step-by-step protocol for designing, hoʻololi, hoʻopili ʻana, and validating peptide standards on Luminex xMAP/MagPlex beads, with tips on EDC/S-NHS chemistry, maʻiʻo peptide net (AAA), and cross-reactivity prevention.

Ka Hoʻolālā ʻana i nā Kūlana Peptide no Luminex Multiplex Immunoassays: He Kuʻuna Mākaukau Lab

Nā pūʻulu hoʻopaneʻe ma muli o ka bead, e like me Luminex xMAP a me nā ʻenehana MagPlex, hilinaʻi ma luna o nā calibrators kiʻekiʻe loa e hoʻopuka i ka ʻikepili quantitative pololei ma waena o nā panela multi-analyte. ʻOiai ua hoʻohana ʻia nā protein lōʻihi recombinant ma ke ʻano he calibrators maʻamau, Ua puka mai nā peptides synthetic i ke kūlana gula no ka helu kikoʻī epitope, hōʻoia biomarker, a me ke kiʻekiʻe-throughput antibody profiling. Hāʻawi nā peptides synthetic i ka stoichiometry i wehewehe ʻia, liʻiliʻi liʻiliʻi loa-a-lot structural variation, a me ka scalability kumu kūʻai.

Ka Hoʻolālā ʻana i nā Kūlana Peptide no Luminex Multiplex Immunoassays: He Kuʻuna Mākaukau Lab

Eia naʻe, ʻO ka unuhi ʻana i kahi kaʻina peptide maka i loko o kahi maʻamau immunoassay i hoʻopaʻa ʻia e koi i ka hoʻolālā kemika ikaika a me ka loiloi bioconjugation.. ʻO nā peptides synthetic liʻiliʻi (<30 nā ʻakika amino) e hōʻike pinepine i ka epitope masking i ka wā i hoʻokuʻu ʻia ma luna o nā microspheres carboxylated, non-specific hydrophobic adsorption, a i ʻole ka hoʻopaʻa ʻana i ka ʻike gravimetric kūpono ʻole ma muli o ka distortion mass counterion.

Hōʻike kēia protocol bench-ready i kahi ʻano hana 5-phase no ka hoʻolālā ʻana, hoʻololi, hoʻopili ʻana, a me ka hooiaio ana nā kūlana peptide no Luminex multiplex immunoassays, e hōʻoia i ka loaʻa ʻana o ka epitope, liʻiliʻi kea-reactivity, a me ka ho'āʻo ikaika i ka reproducibility. Kūʻai nui ʻo Dipeptide

Ka Hoʻolālā ʻana i nā Kūlana Peptide no Luminex Multiplex Immunoassays: He Kuʻuna Mākaukau Lab

Māhele 1: ʻO ke koho ʻana i ke kaʻina a me ka Hoʻohui Hoʻohui

ʻO ka hoʻomaʻemaʻe ʻana i nā peptides synthetic pōkole ma luna o ka polystyrene a i ʻole nā ​​​​ʻili o ka bead magnetic e alakaʻi pinepine ai i ka steric hindrance., kahi e ālai ai ka matrix bead i ke komo ʻana o ka antibody i nā koena paʻa kī. ʻO ka hoʻolālā kaʻina maikaʻi e kaulike i ke kūpaʻa kino, hiki ke hoʻololi, a me ka hōʻikeʻike pūnaewele.

1. Epitope Mapping and Sequence Length

  • ʻIkepili Epitope liʻiliʻi: E ʻike i nā kumu hoʻopaʻa laina kumu a i ʻole conformational hoʻomau (maʻamau 8-15 amino acids).
  • ʻO nā koena ʻaoʻao: E mālama iā 2–4 N- a me C-terminal flanking amino acids no ka mālama ʻana i ka hana lua kūloko a me ka solubility ionic.
  • Hoʻoemi Hydrophobicity: E helu i ka awelika nui o ka hydropathicity (KAHUA) helu helu. Nā kaʻina me nā koena hydrophobic kiʻekiʻe (Trp, Ua haʻi aku ʻo Phe, Leu, Me) e hāʻule ana ma luna o ka hydrophobic polystyrene bead core, alakaʻi i ka paʻa kiʻekiʻe ʻole kikoʻī (NSB). Hoʻohui i nā hōʻailona hoʻonā (e like me Lys-Lys a i ʻole Glu-Glu hoʻohui ma non-epitope termini) inā pono.

2. Nā mea hoʻokaʻawale a me nā mea hoʻopili maʻalahi

E hoʻolālā i ka epitope ma waho o ka papa palena hydrodynamic bead, e hoʻokomo i kahi spacer hydrophilic ma waena o ka lima hoʻopili hana a me ke kaʻina pahuhopu.

Ka Hoʻolālā ʻana i nā Kūlana Peptide no Luminex Multiplex Immunoassays: He Kuʻuna Mākaukau Lab
  • PEG Spacers: Nā loulou polyethylene glycol (PEG2, PEG4, a i ʻole PEG12) hāʻawi i ka hoʻoheheʻe wai maikaʻi a me ka immunogenicity ʻole i hoʻohālikelike ʻia me nā kaulahao hydrocarbon paʻa.
  • Amino-hexanoic Acid (Ahhh): He kūpono no nā kaʻina hydrophilic moderately e koi ana i kahi 1-2 nm offset kino.

No ke kōkua: E kau mau i ka spacer PEG maʻalahi ma waena o ka pūnaewele hoʻohui (e.g., N-terminal amine a i ʻole Cys hope) a me ka epitope. Hiki i ka hoʻopili pololei ʻana me ka ʻole o kahi spacer ke hōʻemi i ka pilina paʻa antibody e 40-70% ma muli o ka pale steric e ka ʻili carboxyl bead.


Māhele 2: Hoʻololi Kūikawā a me ka Lepili Kemika

Hoʻololi ka hui like ʻole a kuhikuhi ʻole i ka hoʻohālikelike ʻana o ka epitope a hoʻoulu i ka hoʻololi ʻana o ka hoʻonohonoho ʻana i ka hui.. ʻO ka hoʻololi kemika kikoʻī o ka pūnaewele e hōʻoiaʻiʻo i ka hōʻike spatial like ʻole ma kēlā me kēia wahi microsphere.

Ka Hoʻolālā ʻana i nā Kūlana Peptide no Luminex Multiplex Immunoassays: He Kuʻuna Mākaukau Lab
Orientational Immobilization Koho kikoʻī
Koho A N-Kuna / Lys Amine PEG4 Spacer → EDC/S-NHS Amide Bond → COOH-MagPlex Bead
Koho B Palena Biotin Tag PEG4 Spacer → Streptavidin Capture → Avidin-MagPlex Bead
Koho C ʻO ka Terminal Cysteine ​​Thiol Maleimide Handle → Thioether Linkage → Amine-MagPlex Bead

1. Biotinylation vs. Hoʻopili pololei ʻo Amine

  • Kūlana Biotinylation: Hoʻohui pū i ka N-terminal Biotin a i ʻole Lys(Biotin) ma o kahi loulou PEG4 hiki ke wikiwiki, immobilization kiʻekiʻe-affinity ma Streptavidin-coated MagPlex microspheres (K d ≈ 10^{-14} M). Hoʻopau kēia i ka pono o ka kemika carbodiimide ma ka bead i ka wā hoʻonohonoho hoʻāʻo.
  • Hoʻopili pololei ʻo Amine: Inā hoʻohana i ka carboxylated (COOH) Nā microspheres MagPlex, e hōʻoia i ka peptide wale nō ʻekahi amine mua (ka N-kumu). Pono e hoʻololi a pale ʻia nā koena Lysine kūloko i loko o ka epitope i ka wā synthesis e pale ai i ka hoʻopili ʻana i nā ʻāpana like ʻole e hoʻopau i ka ʻike antibody..

2. Ka Hoʻopaʻa ʻana o Fluorescent no ka Mana Mana Mea Nui

I ka hōʻoia ʻana i nā kahawai nūhou a i ʻole ka nānā ʻana i ka nui o ka hoʻouka ʻana i ka bead, nā fluorophores orthogonal (e.g., Alexa Fluor 488 a i ʻole FITC) hiki ke hoʻohui ʻia i nā kaulahao ʻaoʻao ʻo Lysine hoʻokūkū ʻole.

  • Hoʻohālikelike Spectral: E hōʻoia i ka hōʻeuʻeu ʻana a me ka hoʻokuʻu ʻana i nā mea kikoʻī ʻaʻole e uhi ʻia me nā lasers hoʻohālikelike Luminex kūloko (ʻulaʻula/infrared dyes ma 658 nm a 712 nm, a i ʻole nā ​​kahawai hoʻolaha ʻōmaʻomaʻo ma 525 nm ma nā ʻōnaehana Intelliflex).

Māhele 3: Luminex MagPlex Bead Coupling Protocol

Nā microspheres xMAP carboxylated (MagPlex COOH) loaʻa nā hui carboxyl ili (~10⁷ COOH/pepa) ka mea e hana me nā amine mua ma o ʻelua mau ʻanuʻu carbodiimide kemika me ka hoʻohana ʻana i ka 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) a me ka N-hydroxysulfosuccinimide (Sulfo-NHS).

Ka Hoʻolālā ʻana i nā Kūlana Peptide no Luminex Multiplex Immunoassays: He Kuʻuna Mākaukau Lab
Kaʻina Kūkākūkā Hoʻopaʻa / Reagent Nā ʻāpana pane Pahuhopu Nui
1. Holoi Lei 100 mM MES, pH 6.0 2.5 × 10⁶ lei, vortex & hoʻokaʻawale magnetic Wehe i nā preservatives mālama a hoʻohālikelike i ka ʻili
2. Ho'ola COOH 50 mg/mL EDC + 50 mg/mL Sulfo-NHS i MES Hoʻopu 20 min ma RT me ka hoʻololi mālie E hoʻolilo iā COOH i paʻa, amine-reactive Sulfo-NHS esters
3. Holoi Ho'ā 50 mM MES, pH 6.0 Holoi 2× me ka ho'āla ho'āla Wehe i ka EDC i hana ʻole ʻia, nā huahana urea, a me ka Sulfo-NHS keu
4. Hoʻohui Peptide PBS (pH 7.2–7.4) + 10–20\ µg peptide Hoʻopu 2 h ma RT a i ka pō ma 4°C Hoʻokumu i nā mea paʻa covalent amide me nā amine mua
5. Ke kinai ana 1 M Ethanolamine (pH 9.0) a i ʻole 50 mM Tris (pH 8.0) Hoʻopu 30 min ma RT Hydrolyze unreacted NHS-esters e pale i ka paʻa ʻole
6. Kāohi ʻana / Waihona PBS, 1% BSA, 0.05% Sodium Azide, pH 7.4 E mālama i ka 2-8 ° C i ka pōʻeleʻele Hoʻopaʻa i nā microspheres conjugated no ka mālama lōʻihi

Nā Kūlana Hoʻokō Hoʻohui Koʻikoʻi

  1. Hoʻolaula Buffer Control: Hana i ka ho'āla carboxyl ma pH 6.0–6.3 i loko o ka MES buffer. Hāʻule nui ka pono EDC ma ka pH > 7.0.
  2. Hoʻomākaukau ʻana i ka Reagent Hou: ʻO EDC a me Sulfo-NHS he hygroscopic a hydrolyze wikiwiki i loko o nā wai wai. E hoʻopau koke i nā aliquot maloʻo ma mua o ka hoʻohui ʻana; mai mālama i nā hoʻonā waiwai i hoʻohui ʻia.
  3. Māhele Hoʻohui ʻAʻohe Amine: I ka wā o Step 4, Pono e hoʻokuʻu ʻia ka pahu hoʻohui i nā amine kumu a i ʻole nucleophiles. E pale iā Tris, glycine, aiʻole ka sodium azide i loko o ka pahu hoʻohui, ʻoiai nā nucleophiles hoʻokūkū e hoʻopau i ka NHS-esters ikaika a hoʻemi i ka hua hui peptide..

⚠️ ʻŌlelo Aʻo: Mai hoʻokomo i ka BSA, serum, a i ʻole gelatin ma mua o ka Step 5. ʻO ka hoʻohui ʻana i nā mea pale protein i ka wā o ka hoʻohui ʻana e hopena i ka conjugation protein kaumaha i nā pahu, e uhi piha i ka maʻamau peptide synthetic.


Māhele 4: Multiplex Cross-Reactivity & Kāohi Hoʻopaʻa Paʻa ʻole

I loko o kahi panela Luminex multiplex (e.g., 10-plex i 50-plex), Hiki ke hoʻololi ʻia ke ʻano ma nā ʻaoʻao ʻelua: ka antibody-to-non-target-peptide paa a peptide-to-bead adsorption kikoʻī ʻole. Mea Hana Peptides Synthetic

1. Matrix Cross-Reactivity Screening (5×5 Hōʻoia Papa Checkerboard)

Ma mua o ka hoʻopaʻa ʻana i kahi panela multiplex, hana i kahi analyte hoʻokahi piha vs. ka nānā ʻana i ka matrix multiplex:

  • Pono e hoʻopili ʻia nā antibodies ʻike mua i kēlā me kēia ʻāpana immobilized peptide bead.
  • ʻAʻole pono e ʻoi aku ka nui o ke kahe ʻana o ka hōʻailona ma nā ʻāpana bead ʻole 1.5% o ka hōʻailona pahuhopu kiko'ī i ka nui o ka hoʻopaʻa ʻana o ka calibrator (B max).
  • Inā loaʻa ka hoʻololi keʻa, e noʻonoʻo inā pili ka kaʻina i ka homology linear (>40%) me nā mea analytes panel off-target. Hoʻololi i nā koena ʻaoʻao a hoʻopōkole paha i ka hana peptide e hoʻonui i ka koho koho.

2. Kāohi ʻana a me ka hoʻēmi ʻana i ka hopena matrix

Nā peptides synthetic me ka pI kiʻekiʻe (>9.0) lawe i nā koina maikaʻi ma ka pH physiological (7.4), e hoʻokau i ka hoʻopaʻa ʻana i ka electrostatically i hoʻopaʻa ʻole ʻia i nā pūʻulu carboxyl i hoʻopaʻa ʻole ʻia ma nā pahu MagPlex.

  • Pākuʻi Lapaʻau: Hoʻokomo 0.05% i 0.1% Ma waena o-20 a i ʻole Triton X-100 i ka hoʻāʻo a me ka holoi ʻana i nā pale e hōʻemi i ka pilina hydrophobic.
  • Nā Palena Poli-Ionic: Hoʻohui 10\ µg/mL heterophilic blocking reagents a haʻahaʻa-molecular-weight dextran sulfate e hōʻemi i ka ionic background i loko o ka serum kanaka a i ʻole nā ​​mea hoʻohālike plasma matrix..

Māhele 5: ʻO ka mana o ka maikaʻi o nā papa he nui (QC) & ʻO ka pololei o ka calibration

Pono ka calibration immunoassay pololei i ka helu pono o ka mea maʻamau kuhikuhi. ʻO ka hilinaʻi wale ʻana i ka nui paona nui e alakaʻi i nā ʻokoʻa ma waena o ka nui..

Nui Peptides Nui (1.0 mg i kaupaonaia)

Wai & Māmā (5–15%)

Kūʻē: TFA / Acetate (10–25%)

ʻOiaʻiʻo Peptide Mass (~ 60–80% kaʻina hana maoli)

1. Hoʻololi Kūʻē Kūʻē (TFA i ka Acetate / HCl)

ʻO ka peptide synthesis paʻa paʻa maʻamau (SPSS) hoʻopuka i nā peptides e like me trifluoroacetate (TFA) paakai ma muli o 0.1% Hoʻohana ʻia ʻo TFA ma RP-HPLC nā ʻāpana kelepona.

  • TFA hemahema: TFA koena (CF_3COO^-) hoʻololi i ka pH assay kūloko, hoʻopau i nā hōʻoia hōʻoia pili pūnaewele, a hoʻohui i 15-30% non-peptidic counterion kaumaha i ka hāpana.
  • Kaʻina Hoʻololi: Hana i ka ion-exchange chromatography a i ʻole lyophilization hou mai 10 mM HCl a i ole 1% acetic acid solution e hoʻololi i ka counterion i nā paʻakai acetate a i ʻole hydrochloride. Pono e hōʻoia ka hoʻololi ʻana e ka ion chromatography a i ʻole capillary electrophoresis e hōʻoia i ke koena TFA ma lalo. 1.0%. Ke kuhi nei ka ʻae like ʻana o nā hoa e pili ana i ke kūʻai kūʻē, ʻO ka hoʻololi ʻana i ka TFA no ka acetate biocompatible he mea nui ia no ka calibration immunoassay reproducible.

2. Maʻiʻo Peptide Net (NPC) ma o ka Amino Acid Analysis (AAA)

ʻO ke kaupaona ʻana o Gravimetric o nā peptides lyophilized e loaʻa ana i ka makū a me nā counterions. Maʻemaʻe Chromatographic (RP-HPLC) ana i ka pakeneka wahi kiʻekiʻe ma waena o nā ʻano peptidic, aka ʻaʻole hōʻike i ka nui non-peptidic.

No ka hoʻokumu ʻana i nā ʻāpana calibrator piha, ana Maʻiʻo Peptide Net (NPC) hoʻohana i ka quantitative Amino Acid Analysis (AAA). E like me ka kikoʻī ma ka ka hoʻoholo ʻana i ka ʻike peptide net ma o ka Amino Acid Analysis protocol: Hoʻololi pololei o ka Cysteine ​​​​i loaʻa nā peptide a i ʻole nā ​​​​proteina e hoʻohana ana i nā paʻakai Alkylthiophenium

Maʻiʻo Peptide Net (NPC %) = Ka nui o nā ʻakika Amino i hōʻoia ʻia/Ka nui o ka nui i kaupaona ʻia × 100

E helu i ka nui o ka peptide ikaika maoli no ka hoʻomākaukau ʻana i ka waiwai:

Kaupaʻa ʻOiaʻiʻo = Kaupaʻa Nui × (RP-HPLC Maʻemaʻe %/100) × (NPC %/100) Kūʻai nui ʻia Polypeptide Synthetic

3. Nā Koina Hoʻokuʻu Lot-to-Lot

E pili ana Pono kēlā me kēia pūʻulu o nā kūlana peptide synthetic i nā paepae hoʻokuʻu ma mua o ka hoʻohui ʻana:

  • Maemae (RP-HPLC): ≥ 95.0% wahi piko nui ma 214 nm a 280 nm.
  • ʻIkepili (HRMS/LC-MS): Hoʻohālikelike ka nuipa monoisotopic i ke kaumaha molekala i loko o ± 0.5 A.
  • Maʻiʻo Peptide Net (AAA): Hāʻawi ʻia ka pākēneka NPC i helu ʻia ma ka palapala hōʻoia (KoA).
  • Ke koena Counterion: TFA koena < 1.0\ w/w%.
  • Hoʻolikelike ʻia ʻo Bead Conjugation: Intra-assay CV < 5.0% ma kela aoao 100 e hoʻopili hou i nā heluhelu lei; ʻano like ʻole o ka lot-to-lot slope < 10.0% ma ka laina laina laina maʻamau.

Hoʻonui i ka Immunoassay Standardization me nā hoʻololi MOL

M Peptides Mea Hoolako ʻO ka hoʻomohala ʻana i nā kūlana peptide koʻikoʻi no ka hoʻāʻo ʻana o Luminex multiplex e koi i ka kemika synthesis kiʻekiʻe, hoʻololi kūikawā, a me QC analytical piha. ʻO ka hui pū ʻana me kahi CDMO kūikawā e hoʻopau i nā bottlenecks synthesis a hōʻoiaʻiʻo i ka waiwai assay-grade.

ʻO ka Hoʻololi ʻo MOL i ka synthesis peptide maʻamau a me ke kahua hoʻololi hāʻawi i nā hopena hope loa no nā mea hoʻomohala immunoassay:

  • 300+ Nā Hoʻololi Hana: ʻO ka biotinylation N/C-kūpono pūnaewele, nā loulou PEG i hoʻopuehu ʻia (PEG2–PEG24), ka hoʻopaʻa inoa ʻana o ka wai ʻulaʻula, a me nā lima hana maʻamau.
  • Ultra-Sterile Production: Hoʻokomo ʻia ka peptide synthesis i loko o ka Papa 100 kaiapuni lumi maemae, hōʻoia i nā pae endotoxin ultra-haʻahaʻa (<0.01 EU/mg) no nā bioassay koʻikoʻi.
  • ʻO ka hōʻoia ʻana i ka hoʻopaʻa ʻana: Hāʻawi ʻia kēlā me kēia maʻamau maʻamau me nā palapala CoA piha, me ka hoʻonā kiʻekiʻe LC-MS mass spectra, analytical RP-HPLC chromatograms, Maʻiʻo Peptide Net i hōʻoia ʻia e AAA, a ua hōʻoia ʻia ka hoʻololi counterion TFA-to-acetate.

Ke hoʻokumu nei i nā panela biomarker mua a i ʻole ka hoʻonui ʻana i nā pahu diagnostic multiplex pāʻoihana, leveraging kiʻekiʻe-maʻemaʻe, ʻO nā peptides synthetic i hōʻike piha ʻia e hōʻoia i ka reproducibility a me ka hoʻokō lōʻihi.


Hōʻuluʻulu Manaʻo Papa inoa

  • E koho i 8-15 amino acid core epitope; hoʻohui i ka loulou hydrophilic PEG2/PEG4 ma ka hoʻohui ʻana.
  • Hoʻohui i ka biotinylation kikoʻī pūnaewele a i ʻole hoʻokahi N-terminal primary amine.
  • Hana i ka hoʻololi counterion mai TFA i ka paʻakai acetate (TFA koena <1.0%).
  • E hoʻoholo i ka maʻiʻo Peptide Net (NPC) ma o AAA; hoʻololi i ka hoʻomākaukau ʻana o ka calibrator stock e like me ia.
  • E ho'ā i nā pahu MagPlex COOH i loko 100 mM MES (pH 6.0) me ka EDC/Sulfo-NHS hou.
  • ʻO nā peptide kāne i loko o ka amine-free PBS (pH 7.2–7.4); e kinai i na esters unreacted me Ethanolamine a i ole Tris/Casein.
  • E hōʻoia i ka cross-reactivity me ka hoʻohana ʻana i ka pale matrix 5x5 (hōʻailona kūwaho <1.5%).
Zejun Peng

Zejun Peng

Luna ʻenehana Nui; ʻO ka mea akamai i ka peptide Synthesis Kaʻike kumu: ʻO ka peptide synthesis paʻakikī, nā hoʻololi ʻana o ka amino acid kūlohelohe, a me ke kūkulu ʻana i nā peptides cyclic a me nā peptides stapled.

moʻokalaleo:He ʻike nui ʻo Zejun Peng i ka kemika kūlohelohe a me ka synthesis peptide. Maikaʻi ʻo ia i ka hoʻohana ʻana o ka solid-phase peptide synthesis (SPSS) a me ka peptide synthesis wai (LPPS), a akamai loa i ka lanakila ʻana i nā "paʻakikī loa-e-synthesize sequences" (e like me nā peptides ultra-long-chain, nā kaʻina hydrophobic kiʻekiʻe, a me ka pelu ana i na mea paa disulfide lehulehu). Ma lalo o kāna alakaʻi, ua lanakila ka hui i nā bottlenecks ʻenehana i kekahi mau hoʻololi kūikawā (e like me ka N-methylation, PEGylation, a me ka lepili fluorescent), ka mālama ʻana i ka helu kūleʻa synthesis o luna 98%.

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana